launch button
Pharma

Analysts pin high hopes early on Lilly's Foundayo launch

Meanwhile, Novo Nordisk—intent on keeping hold of its first-mover advantage in the obesity pill space—is mounting a proactive defense of oral Wegovy.
Fraiser Kansteiner Apr 2, 2026 11:42am
Trump Donald Trump

Trump eyes 100% tariff rate for imported drugs: Bloomberg

Apr 2, 2026 11:56am
HCPengagementis stuck in the past hereshowpre-consultprecision unlockswhatsnext

Smarter HCP engagement starts earlier

Brought to you by Phreesia Network Solutions
Britain Big Ben United Kingdom London

UK government agrees to pharma deal, ensuring tariff reprieve

Apr 2, 2026 3:34pm
BioNTech

BioNTech to turn out the lights at Singapore vaccine facility

Apr 2, 2026 2:51pm
Rising Stars in Pharma Marketing QA series header image

Rising Stars: Elizabeth Keenan finds the rhythm in music, media

Apr 2, 2026 2:46pm
More News

Poland, Romania ordered to pay $2.2B in Pfizer COVID vax suit

Apr 2, 2026 11:56am

Another AstraZeneca Emerald glimmers in liver cancer

Apr 2, 2026 10:12am

Regulatory tracker: Vertex cystic fibrosis meds win wider labels

Apr 1, 2026 10:20am

UK cost watchdog clears Novo's Wegovy for cardio risk reduction

Apr 1, 2026 9:38am